INTRODUCTION
roup B streptococcus (GBS) has been identified as an important and lethal pathogen in the bacterial disease of the newborn and is the leading cause of neonatal sepsis and meningitis in the United States. [1] [2] [3] The GBS infection rate is approximately one to three per 1000 live births and carries with it a mortality rate of 20%. 3, 4 Despite adequate numbers of clinical trials that demonstrate the effectiveness of intrapartum antibiotic prophylaxis, the incidence of neonatal GBS disease has remained unchanged due to inconsistent prevention strategies, s Colonization with GBS is common among pregnant women, with an incidence of 15% to 40%. 3, 6 Because GBS carriage in the reproductive tract of pregnant women is intermittent and may be transient, the intensity and presence of intrapartum GBS colonization are the key factors involved in vertical transmission to the infant. 3, 7 Vertical transmission rates range from 30% to 70% of culturepositive women to neonates, but only 1% to 2% of these neonates go on to develop GBS disease. 8 The risk of neonatal infection rises when certain risk factors are present. These risk factors include: premature rupture of membranes, preterm labor, prolonged rupture of membranes, a previously-GBS-affected sibling, heavy maternal GBS colonization, and maternal fever during labor. 3 The standard method for GBS detection is a broth culture obtained from vaginal and rectal swab specimens. The specimens are stored and transported in a compact medium until they can be processed and cultured. The standard culture method is both sensitive and specific, but because this procedure employs primary incubation in a selective broth for an 18-24-hour period, multiple rapid GBS detection tests 
RESULTS
The sample characteristics are shown in Table 1 and the culture and OIA results in Table 2 
